Tonix Pharmaceuticals Holding (TNXP) Enterprise Value (2023 - 2025)
Historic Enterprise Value for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to -$190.1 million.
- Tonix Pharmaceuticals Holding's Enterprise Value fell 57316.62% to -$190.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$190.1 million, marking a year-over-year decrease of 57316.62%. This contributed to the annual value of -$98.8 million for FY2024, which is 29592.75% down from last year.
- According to the latest figures from Q3 2025, Tonix Pharmaceuticals Holding's Enterprise Value is -$190.1 million, which was down 57316.62% from -$125.3 million recorded in Q2 2025.
- Tonix Pharmaceuticals Holding's Enterprise Value's 5-year high stood at -$4.2 million during Q2 2024, with a 5-year trough of -$190.1 million in Q3 2025.
- Its 3-year average for Enterprise Value is -$65.0 million, with a median of -$28.2 million in 2024.
- As far as peak fluctuations go, Tonix Pharmaceuticals Holding's Enterprise Value soared by 9020.63% in 2024, and later crashed by 291566.41% in 2025.
- Over the past 3 years, Tonix Pharmaceuticals Holding's Enterprise Value (Quarter) stood at -$24.9 million in 2023, then tumbled by 295.93% to -$98.8 million in 2024, then crashed by 92.41% to -$190.1 million in 2025.
- Its Enterprise Value was -$190.1 million in Q3 2025, compared to -$125.3 million in Q2 2025 and -$131.7 million in Q1 2025.